Second Sight Medical Products, Inc. (EYES): Price and Financial Metrics


Second Sight Medical Products, Inc. (EYES): $2.17

0.06 (+2.59%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

EYES Stock Price Chart Interactive Chart >

Price chart for EYES

EYES Price/Volume Stats

Current price $2.17 52-week high $7.64
Prev. close $2.12 52-week low $1.14
Day low $2.02 Volume 346,700
Day high $2.18 Avg. volume 488,888
50-day MA $1.54 Dividend yield N/A
200-day MA $2.13 Market Cap 85.52M

Second Sight Medical Products, Inc. (EYES) Company Bio


Second Sight Medical Products develops, manufactures, and markets implantable prosthetic devices to restore functional vision to blind patients in the United States, Canada, Europe, and Saudi Arabia. The company was founded in 1998 and is based in Sylmar, California.


EYES Latest News Stream


Event/Time News Detail
Loading, please wait...

EYES Latest Social Stream


Loading social stream, please wait...

View Full EYES Social Stream

Latest EYES News From Around the Web

Below are the latest news stories about Second Sight Medical Products Inc that investors may wish to consider to help them evaluate EYES as an investment opportunity.

EYES Stock Pops on Biotech Merger Plans. 5 Things to Know.

EYES stock is up 15% today on news that Second Sight Medical is making a strategic acquisition.

Joel Baglole on InvestorPlace | February 8, 2022

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

Good morning!

William White on InvestorPlace | February 8, 2022

Second Sight Medical To Merge With AstraZeneca-Backed Nano Precision Medical

Second Sight Medical Products Inc (NASDAQ: EYES) will acquire privately-held Nano Precision Medical Inc in an all-stock transaction. Second Sight Medical develops implantable visual prosthetics. Under the agreement, Nano Precision Medical will merge with a wholly-owned subsidiary of Second Sight. The surviving company Nano Precision Medical will be owned by Second Sight. The newly-formed merged company will focus on developing innovative implants for chronic diseases. The combined company will b

Yahoo | February 8, 2022

Second Sight Medical Products and Nano Precision Medical Announce Merger Agreement to Create Leading Therapeutic Implant Company

LOS ANGELES & EMERYVILLE, Calif., February 07, 2022--Second Sight Medical Products, Inc. (NASDAQ: EYES) (the "Company" or "Second Sight") and Nano Precision Medical, Inc. ("NPM"), today announced that they have entered into a definitive agreement under which privately held NPM will merge with a wholly owned subsidiary of Second Sight in an all-stock transaction. NPM will be the surviving company and owned by Second Sight. The resulting company will focus on development of innovative drug and dev

Yahoo | February 7, 2022

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

Good morning, trader!

William White on InvestorPlace | November 17, 2021

Read More 'EYES' Stories Here

EYES Price Returns

1-mo 46.62%
3-mo 65.65%
6-mo 9.60%
1-year -63.71%
3-year -65.28%
5-year -76.41%
YTD 33.13%
2021 -12.83%
2020 -68.50%
2019 -16.63%
2018 -53.40%
2017 -3.05%

Continue Researching EYES

Want to see what other sources are saying about Second Sight Medical Products Inc's financials and stock price? Try the links below:

Second Sight Medical Products Inc (EYES) Stock Price | Nasdaq
Second Sight Medical Products Inc (EYES) Stock Quote, History and News - Yahoo Finance
Second Sight Medical Products Inc (EYES) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.5622 seconds.